A 1636 New Jersey General Assembly · 2026-2027 Regular Session

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

This New Jersey bill (A 1636) classifies 7-Hydroxymitragynine as a Schedule I controlled substance and bans the sale, manufacture, and distribution of any product containing it. The law requires manufacturers and distributors to immediately recall any products containing the substance, mandates retailers to remove such products from shelves within 48 hours, and requires retailers to return recalled inventory to manufacturers within 30 business days. Violations are punishable as crimes, ranging from fourth-degree offenses for first violations to second-degree crimes for repeat offenses. The bill directly affects businesses selling or handling products with 7-Hydroxymitragynine, including manufacturers, distributors, and retailers.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Consumer Affairs Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Sean Kean
Sean Kean
RRepublican
NJ
30